Rapid qualitative profiling and quantitative analysis of Juglandis Mandshuricae Cortex and seven flavonoids by ultra-high performance liquid chromatography–quadrupole/orbitrap high-resolution mass spectrometry

Juglandis Mandshuricae Cortex is the bark of Juglans mandshurica Maxim., which has been used as a folk medicine plant in China and India. In this study, an ultra-high performance liquid chromatography–quadrupole/orbitrap high-resolution mass spectrometry method was developed to clarify and quantify the chemical profiling of Juglandis Mandshuricae Cortex rapidly. A total of 113 compounds were characterized. Among them, seven flavonoids were simultaneously quantified in 15 min, including myricetin, myricetrin, taxifolin, kaempferol, quercetin, quercitrin, and naringenin. The method was validated for accuracy, precision, and the limits of detection and quantification. All calibration curves showed a good linear relationship (r > 0.9990) within test ranges. The intra- and inter-day relative standard deviations were less than 2.16%. Accuracy validation showed that the recovery was between 95.6 and 101.3% with relative standard deviation values below 2.85%. The validated method was successfully applied to determine the contents of seven flavones in Juglandis Mandshuricae Cortex from seven sources and the contents of these places were calculated respectively. This method provides a theoretical basis for further developing the medicinal value of Juglandis Mandshuricae Cortex.     

基于基金项目的“一带一路”研究格局与态势分析

以国家和有关部委的资助项目库为数据来源，检索2014-2016年“一带一路”的相关基金立项，运用文献计量和空间分析的方法从项目的负责人、科研单位、所属地域、学科、研究内容等多个角度进行解析，旨在揭示 “一带一路”研究的格局与态势.结果表明：（1）“一带一路”相关基金立项数目总体呈逐年上升趋势，增速平缓，国家社科基金主体地位明显.（2）项目所属单位、省份在空间上呈现集中分布趋势，体现了一定的区位优势、空间关联与地理邻近效应.（3）单个负责人的立项数目差异不大，分布较为平均.（4）“一带一路”、丝绸之路经济带、21世纪海上丝绸之路为目前学者主要的研究对象和议题.（5）各类基金高频词汇基本保持同步，五类基金研究的热门领域大体趋于一致，包括经济学、国际问题研究、民族问题研究和交叉学科研究等.最后，从研究数据、时间、空间及学科与合作前景上，对未来的研究趋势做了总结和展望.     

中红外光谱结合向量夹角直接定量三氯蔗糖

多组分复杂体系的红外光谱由于成分多样、谱带严重重叠、背景干扰等导致谱图特征减弱，且体系中的红外光谱往往不是各组分光谱的简单叠加，需要借助于化学计量学技术以实现解析。基于朗伯-比尔定律（Lambert-Beer law）并且随着衰减全反射（ATR）技术取样普及，结合偏最小二乘回归法（PLS）、人工神经网络（artificial neural network, ANN）等化学计量法将数据进行累积、特征提取以及校正建模等工作解决红外光谱中严重重叠和非线性等问题，再采用二次测量定量分析已初步具有应用成效，而有效增强信息量表达，降低背景、噪声干扰，减少复杂的计算过程，进而保证定量分析结果的可靠性，则成为研究的主要方向。通过讨论光通道和背景对光谱强度变化的影响，结合向量角度转换提出一种新的近似线性定量方法。经初步理论计算，发现多组分混合物与该混合物中待测组分的相对含量二者间的向量夹角值存在一定的关系，而该关系并不受批次制样的影响，进一步通过高斯曲线模拟混合信号，充分说明选择合适的波长范围，二者在一定范围内存在线性相关性，相关性不受测量条件变化的影响。采用KBr压片法，向待测样品中逐步加入待测组分得到混合样本，分别得到待测组分光谱与混合样本光谱信号，先将其进行一阶求导，消除加性误差后，再将其转化为空间向量角度，消除批次制样中光程差异，再以百分比定义待测物样品的含量，所得到混合样的夹角值与其中所含参照品含量成简单线性关系，即以计算结果夹角值与含量作标准曲线，实现定量分析。本测量方法用于三氯蔗糖（Sucralose, TGS）与三氯蔗糖-6-乙酸酯（4,1,6-trichloro sucrose-6-acetate, TGS-6-A）二者进行一定比例混合（双组分体系），以及TGS-6-A的脱酰产物（多组分体系）中的TGS的含量定量分析，在两种体系中定量均得到令人满意的结果，所建立标准曲线的相关系数r均达到0.995 0以上，相对误差均低于8.0%，所建立的分析方法对利用中红外透射光谱分析研究多组分样品具有重要的参考价值。     

GPR40 受体苯丙酸类激动剂三维定量构效关系研究

苯丙酸类化合物是G蛋白偶联受体40(GPR40)潜在的生物活性药物。本文基于比较分子力场分析法(Co MFA)和比较分子相似性指数分析法(CoMSIA),分别建立了40个已知活性的GPR40受体苯丙酸类激动剂的三维定量构效关系(3D-QSAR)模型,研究该类激动剂与生物活性之间的关系。CoMFA和CoMSIA模型的交叉验证系数(q~2)分别为0. 527和0. 500,拟合验证系数(r~2)分别为0. 901和0. 860,两个3D-QSAR模型预测值与实验值基本一致,表明模型具有良好的可信度和预测能力。根据两个3D-QSAR模型提供的立体场、静电场、疏水场、氢键供体场和氢键受体场所提供的信息提出优化该类抑制剂结构的药物设计思路,为指导设计更高活性的GPR40激动剂以及GRR40新分子激动活性的预测提供理论依据。     

Simultaneous quantitation of 23 bioactive compounds in Tanreqing capsule by high‐performance liquid chromatography electrospray ionization tandem mass spectrometry

Tanreqing capsule (TRQC) is a formulation frequently used in traditional Chinese medicine to treat pyrexia, cough, expectoration and pharyngalgia. Since the pharmacological action of traditional Chinese medicines is closely related to their complex and diverse constituents, understanding the exact composition of TRQC is important to elucidate its clinical effectiveness and mechanism of action as well as to establish quality control methods and resolve safety issues. Herein, we employed high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry for the simultaneous quantitation of 23 bioactive compounds in five batches of TRQC; the analytes could be categorized into five types: organic acids (seven compounds), flavonoids (10 compounds), iridoids (two compounds), phenylethanoid glycosides (two compounds) and bile acids (two compounds). The calibration curves for all analytes showed good linearity (r > 0.9953), and the inter‐ and intra‐day precisions did not exceed 4.94 and 4.97%, respectively. The recoveries varied from 90.47% to 109.80%; the corresponding relative standard deviations (RSDs) did not exceed 4.94%; and the repeatability (RSD < 4.72%) and stability (RSD < 4.88%) were also within acceptable limits. Thus, this study can be viewed as a fundamental reference for setting comprehensive TRQC quality standards.     

拉曼光谱编码的荧光液相生物芯片检测系统研究

随着医疗诊断需求的增加，生物分子检测技术越来越受到人们的重视，液相生物芯片技术作为一种高通量，多通道的分子检测手段在近几年得到了飞速发展。通过层层自组装方法制备以微片为载体的拉曼光谱编码液相生物芯片，并利用自行搭建的一套高灵敏度、高分辨率的光学系统，实现对液相生物芯片的定性与定量分析。光学系统由拉曼光谱检测系统与荧光显微成像系统耦合而成。在拉曼光谱检测系统中激光器发射出785 nm波长的激光，通过二向色镜，带反反射镜与物镜汇聚到样品上，样品产生的拉曼散射光，经物镜，带反反射镜，二向色镜与拉曼滤波片，最后通过凹透镜聚焦到光谱仪的狭缝上，光谱仪色散实现在线阵CCD上拉曼光谱的获取。荧光显微成像系统应用光学成像原理，通过调节凹透镜与405 nm的激发光之间的距离，使激发光通过物镜均匀的照射到样品之上，样品激发出的荧光，通过物镜，带反反射镜，二向色镜，滤波片与相应的凹透镜，最后成像到面阵CCD上。改进传统便携式拉曼光谱检测系统光路并选用相应波段的带反反射镜与焦距20倍的物镜完成拉曼光谱检测系统与荧光显微成像系统的耦合。为了减少两路系统之间的相互影响选用合适的二向色镜以及滤波片，在提高耦合系统获取数据的准确性中有着重要的作用。该系统通过对反应之后的液相生物芯片进行拉曼光谱检测，以完成对每个编码玻片的定性识别，即解码；同时激发反应后液相生物芯片的荧光并采集荧光强度图，根据每个解码玻片上的荧光强度值完成对目标检测物的定量分析。区别于传统荧光编码液相生物芯片, 拉曼光谱编码具有稳定性更强，光谱分辨率更高等优点。该光学系统集拉曼光谱检测系统与荧光显微成像系统于一体，解决了目前未有基于拉曼编码的液相生物芯片的检测系统的问题，并且可同时对多种目标物进行识别和定量分析，提升了实验结果的准确性。     

Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry

The use of quantitative nuclear magnetic resonance spectrometry for the determination of non‐UV active memantine hydrochloride with relative simplicity and precision has been demonstrated in this study. The method was developed on a 500 MHz NMR instrument and was applied to determination of the drug in a tablet formulation. The analysis was performed by taking caffeine as an internal standard and D₂O as the NMR solvent. The signal of methyl protons of memantine hydrochloride appeared at 0.75 ppm (singlet) relative to the signal of caffeine (internal standard) at 3.13 ppm (singlet). The method was found to be linear (r² = 0.9989) in the drug concentration range of 0.025 to 0.80 mg/ml. The maximum relative standard deviation for accuracy and precision was <2. The limits of detection and quantification were 0.04 and 0.11 mg/ml, respectively. The robustness of the method was revealed by changing nine different parameters. The deviation for each parameter was also within the acceptable limits. The study highlighted possibility of direct determination of memantine hydrochloride in pure form and in its marketed tablet formulation by the use of quantitative NMR, without the need of derivatization, as is the requirement in HPLC studies. Copyright © 2016 John Wiley & Sons, Ltd.     

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax

The Bcl-2 family small molecule inhibitor navitoclax is being clinically evaluated to treat multiple cancers including lymphoid malignancies and small cell lung cancer. A sensitive and reliable method was developed to quantitate navitoclax in human plasma using liquid chromatography with tandem mass spectrometry with which to perform detailed pharmacokinetic studies. Sample preparation involved protein precipitation using acetonitrile. Separation of navitoclax and the internal standard, navitoclax-d8, was achieved with a Waters Acquity UPLC BEH C₁₈ column using isocratic flow over a 3 min total analytical run time. A SCIEX 4500 triple quadrupole mass spectrometer operated in positive electrospray ionization mode was used for the detection of navitoclax. The assay range was 5–5,000 ng/ml and proved to be accurate (89.5–104.9%) and precise (CV ≤ 11%). Long-term frozen plasma stability for navitoclax at −70°C was at least 43 months. The method was applied for the measurement of total plasma concentration of navitoclax in a patient receiving a 250 mg daily oral dose.     

基于新巴塞尔协议监管下保险人的均值-方差最优投资-再保险问题

本文研究了均值-方差优化准则下,保险人的最优投资和最优再保险问题.我们用一个复合泊松过程模型来拟合保险人的风险过程,保险人可以投资无风险资产和价格服从跳跃-扩散过程的风险资产.此外保险人还可以购买新的业务(如再保险).本文的限制条件为投资和再保险策略均非负,即不允许卖空风险资产,且再保险的比例系数非负.除此之外,本文还引入了新巴塞尔协议对风险资产进行监管,使用随机二次线性(linear-quadratic,LQ)控制理论推导出最优值和最优策略.对应的哈密顿-雅克比-贝尔曼(Hamilton-Jacobi-Bellman,HJB)方程不再有古典解.在粘性解的框架下,我们给出了新的验证定理,并得到有效策略(最优投资策略和最优再保险策略)的显式解和有效前沿.